Matthew M. Murawski
1979 B.S., Pharmacy, The Philadelphia College of Pharmacy and Science
My current major focus is the _AD_verse _D_rug _R_eaction/_E_vent _S_creening _S_ystem (ADDRESS), an application we have developed for discerning ongoing, high incidence ADE/ADRs (side effects to the layperson) in the ambulatory population. The system is multilingual and designed to be as psychometrically efficient as possible. See: https://www.pharmacy.purdue.edu/ptrqol/
I have a long-term interest in the development and evolution of Advance Practice Models in Pharmacy, such as the Pharmacy Acts currently in place in New Mexico, North Carolina, and Montana, and the barriers to success in those states and the lag-time of adoption elsewhere in the country.
I’ve spent considerable time working with and developing PROs (Patient reported Outcomes) instruments, especially Health-Related Quality of Life (HRQoL). A reasonably competent psychometrician.
Finally, to pursue many of the questions I have found interesting over the years, I have a nuanced and well-developed expertise in survey research, as it is often the only way to survey the field in a new area.
PHRM 831, Health Care Systems
PHAD 243, Pharmacy and the Health Care System
PHAD 464, Marketing Research
PHAD 490, Special Topics, independent study
PHAD 690, Pharmacoeconomics
PHAD 696, Seminar in Pharmacy Administration
PHPR 313, Chemical Dependency
PHPR 664, Research Techniques and Proposal Development
PHPR/MCMP 316, Drug Abuse & Chemical Dependency
HSCI 120, Public Health
Honors and Credentials
Entrepreneurial Leadership Academy Scholar, Burton D. Morgan Center for Entrepreneurship
Entrepreneurial Leadership Academy Fellowship, Burton D. Morgan Center for Entrepreneurship
Dr. Aziz Outstanding Teacher of the Year
Wintergreen Pharmacy Administration Research Conference, University of Maryland Center for Drugs and Public Policy, invited participant, 1999
American Association of Colleges of Pharmacy New Investigator Award Development and Validation of a Pharmaceutical Therapy Related Quality of Life Instrument
Wintergreen Pharmacy Administration Research Conference, University of Maryland Center for Drugs and Public Policy, invited participant, 1996
1. Hagemeier, Ne, Alamian, A, Murawski, MM, Flippin, H, Hagy, EJ, Pack, RP. Correlates of Prescription Opiod Legitimacy Judgments Among Community Pharmacists. Substance Use & Misuse 2015; 51:6, 692-699. Doi: 10.3109/10826084.2015.1135952.
2. Jonathan C. Hale, Matthew M. Murawski, and Timothy J. Ives. Practice Characteristics and Georgraphic Distribution of Clinical Pharmacist Practitioners in North Carolina. North Carolina Medical Journal September 2015;76:205-210. DOI: 10.18043/ncm.76.4.205.
3. Hagemeier NE, Alamian AA, Murawski MM, Pack RP. Factors associated with provision of addiction treatment facility information by community pharmacists. Journal of Substance Abuse Treatment 2015;52:67-72.
4. Hagemeier, Nicholas E., Matthew Murawski, Chris Lopez, Arsham Alamian, Robert Pack. An Instrument to Assess Subjective Task Value Beliefs Regarding the Decision to Pursue Postgraduate Training. American Journal of Pharmaceutical Education 2014; 78:1, Article 11.
5. Dole EJ, Murawski MM, Adolphe AB, Aragon FD, Hochstadt B. Provision of pain management by a pharmacist with prescribing authority. Am J Health Syst Pharm 2007;64:85-89.
6. Jonathan C. Hale, Matthew M. Murawski, and Timothy J. Ives. Perceived successes and challenges of clinical pharmacist practitioners in North Carolina. J Am Pharm Assoc. 2013; 53(6):640-643. DOI: 10.1331/JAPhA.2013.12184.
7. Murawski MM, Bentley J. Pharmaceutical Therapy-Related Quality of Life: Conceptual Development. Social and Administrative Pharmacy 2000;18(1):2-14.
8. Hagemeier NE, Murawski MM, Popovich Ng. The Influence of Faculty Mentors on Junior Pharmacy Faculty Members’ Career Decisions. American Journal of Pharmaceutical Education 2013;77(3):Article 51.
Murawski MM, Meiderhoff P. On the Generalizability of Statistical Expressions of Health-Related Quality of Life Instrument Responsiveness: A Research Synthesis. Qual. Life Res. Jan 1998;7(1): 11-22.
9. Szeinbach, S, Barnes, J, McGhan, W, Murawski, MM, Corey, R. Using Conjoint analysis to Evaluate Health State Preferences. Drug Inf. J. 1999;Vol.33:849-858.